DD123329A5 - - Google Patents
Info
- Publication number
- DD123329A5 DD123329A5 DD190370A DD19037075A DD123329A5 DD 123329 A5 DD123329 A5 DD 123329A5 DD 190370 A DD190370 A DD 190370A DD 19037075 A DD19037075 A DD 19037075A DD 123329 A5 DD123329 A5 DD 123329A5
- Authority
- DD
- German Democratic Republic
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742461312 DE2461312A1 (de) | 1974-12-23 | 1974-12-23 | D-homo-20-keto-pregnane und verfahren zu ihrer herstellung |
| DE19752506688 DE2506688A1 (de) | 1975-02-14 | 1975-02-14 | D-homo-19-nor-20-ketopregnane und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD123329A5 true DD123329A5 (enExample) | 1976-12-12 |
Family
ID=25768157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD190370A DD123329A5 (enExample) | 1974-12-23 | 1975-12-19 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4056633A (enExample) |
| JP (1) | JPS5188953A (enExample) |
| AU (1) | AU501685B2 (enExample) |
| CA (1) | CA1051868A (enExample) |
| DD (1) | DD123329A5 (enExample) |
| DK (1) | DK138501C (enExample) |
| ES (1) | ES443825A1 (enExample) |
| FR (1) | FR2295739A1 (enExample) |
| GB (1) | GB1538869A (enExample) |
| IL (1) | IL48628A0 (enExample) |
| LU (1) | LU74087A1 (enExample) |
| NL (1) | NL7514976A (enExample) |
| SE (1) | SE7514514L (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4104306A (en) * | 1976-05-05 | 1978-08-01 | Abbott Laboratories | 12A-Deoxy chelocardin |
| US5439900A (en) * | 1993-02-25 | 1995-08-08 | Bukusoglu; Cuneyt | Methods and compositions for providing analgesia and enhanced anesthesia |
| CA2495412A1 (en) * | 2002-08-16 | 2004-02-26 | Pharmacia & Upjohn Company | 5 androsten-3.beta.-ol steroid intermediates and processes for their preparation |
| US20070066579A1 (en) * | 2002-08-16 | 2007-03-22 | White Michael J | 5-androsten-3beta-ol steroid intermediates and processs for their preparation |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| WO2014169832A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| WO2014169831A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof |
| MX362543B (es) | 2013-04-17 | 2019-01-24 | Sage Therapeutics Inc | Esteroides c21-n-pirazolilo 19-nor c3,3- disustituidos y metodos de uso de los mismos. |
| HRP20210610T1 (hr) | 2013-07-19 | 2021-05-28 | Sage Therapeutics, Inc. | Neuroaktivni steroidi, pripravci i njihove uporabe |
| PT3035940T (pt) | 2013-08-23 | 2019-01-28 | Sage Therapeutics Inc | Esteroides neuroativos, composições e seus usos |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| EP3885352B1 (en) | 2014-10-16 | 2024-11-27 | Sage Therapeutics, Inc. | A compound, compositions thereof and this compound for use in methods of treating cns disorders |
| EP4275748A3 (en) | 2014-10-16 | 2024-01-03 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| RS60343B1 (sr) | 2014-11-27 | 2020-07-31 | Sage Therapeutics Inc | Kompozicije i postupci za lečenje poremećaja cns-a |
| SMT202100113T1 (it) | 2015-01-26 | 2021-05-07 | Sage Therapeutics Inc | Composizioni e metodi per trattare disturbi del snc |
| EP3258939B1 (en) | 2015-02-20 | 2022-09-07 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| AU2017296295B2 (en) | 2016-07-11 | 2022-02-24 | Sage Therapeutics, Inc. | C7, C12, and C16 substituted neuroactive steroids and their methods of use |
| MA45599A (fr) | 2016-07-11 | 2019-05-15 | Sage Therapeutics Inc | Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation |
| AU2018392093B2 (en) * | 2017-12-22 | 2024-02-01 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| US11718642B2 (en) * | 2018-01-12 | 2023-08-08 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| TW202521129A (zh) | 2018-12-05 | 2025-06-01 | 美商賽吉醫療公司 | 神經活性類固醇及其使用方法 |
| KR102821994B1 (ko) * | 2019-01-08 | 2025-06-19 | 쳉두 캉홍 파마슈티칼 코., 엘티디. | 스테로이드 화합물, 및 이의 용도와 제조방법 |
| AR119047A1 (es) | 2019-05-31 | 2021-11-17 | Sage Therapeutics Inc | Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc |
| CN114787174A (zh) * | 2019-06-27 | 2022-07-22 | 萨奇治疗股份有限公司 | 用于治疗cns病症的组合物和方法 |
| CA3143545A1 (en) * | 2019-06-27 | 2020-12-30 | Sage Therapeutics, Inc. | Compounds for treating cns disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3876705A (en) * | 1972-06-12 | 1975-04-08 | Univ New Brunswick | Steroid total synthesis and intermediates |
-
1975
- 1975-12-09 IL IL48628A patent/IL48628A0/xx unknown
- 1975-12-17 US US05/641,602 patent/US4056633A/en not_active Expired - Lifetime
- 1975-12-17 AU AU87637/75A patent/AU501685B2/en not_active Expired
- 1975-12-19 DD DD190370A patent/DD123329A5/xx unknown
- 1975-12-22 GB GB52351/75A patent/GB1538869A/en not_active Expired
- 1975-12-22 LU LU74087A patent/LU74087A1/xx unknown
- 1975-12-22 SE SE7514514A patent/SE7514514L/xx unknown
- 1975-12-23 ES ES443825A patent/ES443825A1/es not_active Expired
- 1975-12-23 CA CA242,439A patent/CA1051868A/en not_active Expired
- 1975-12-23 DK DK588775A patent/DK138501C/da active
- 1975-12-23 FR FR7539458A patent/FR2295739A1/fr not_active Withdrawn
- 1975-12-23 NL NL7514976A patent/NL7514976A/xx not_active Application Discontinuation
- 1975-12-23 JP JP50153888A patent/JPS5188953A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU501685B2 (en) | 1979-06-28 |
| DK588775A (da) | 1976-06-24 |
| CA1051868A (en) | 1979-04-03 |
| SE7514514L (sv) | 1976-06-24 |
| IL48628A0 (en) | 1976-02-29 |
| GB1538869A (en) | 1979-01-24 |
| NL7514976A (nl) | 1976-06-25 |
| DK138501B (da) | 1978-09-18 |
| AU8763775A (en) | 1977-06-23 |
| FR2295739A1 (fr) | 1976-07-23 |
| LU74087A1 (enExample) | 1976-07-20 |
| DK138501C (da) | 1979-02-19 |
| JPS5188953A (en) | 1976-08-04 |
| ES443825A1 (es) | 1977-05-01 |
| US4056633A (en) | 1977-11-01 |